3D Translabial Ultrasound for Pessary Size Estimation
Evaluation of 3D Translabial Ultrasound Imaging for Pessary Size Estimation
Study Overview
Status
Status
Conditions
Conditions
Intervention / Treatment
Intervention / Treatment
Detailed Description
Study Type
Study Type
Enrollment (Actual)
Enrollment
Phase
Phase
- Not Applicable
Contacts and Locations
Study Locations
-
-
Ontario
-
London, Ontario, Canada, N6A 3K7
- Western University
-
-
Participation Criteria
Eligibility Criteria
Eligibility Criteria
Ages Eligible for Study
- Child
- Adult
- Older Adult
Accepts Healthy Volunteers
Description
Inclusion Criteria:
- are current pessary users (> 6 months) who have no pessary related complication, including discomfort, vaginal bleeding, and pessary extrusion
- are able to provide informed consent
- can perform self-care, i.e. removing and inserting the pessary themselves
- are willing to remove their pessary two days before the ultrasound examination date
Exclusion Criteria:
- inability to give informed consent
- inability to communicate with the person performing the consent and the sonographer performing ultrasound scanning
- history of pelvic radiation or surgery (excluding hysterectomy)
- using pessaries other than ring, incontinence dish, donut, Shaatz
- inability to perform the Valsalva maneuver or pelvic floor contraction
- restricted mobility that prevents them from ambulating to assess the comfort level of the pessary during the initial pessary fitting visit
- lack of sensation at the pelvic floor
- being pregnant at the time of the examination
Study Plan
How is the study designed?
Design Details
- Primary Purpose: Other
- Allocation: N/A
- Interventional Model: Single Group Assignment
- Masking: None (Open Label)
Number of Arms
Arms and Interventions
Participant Group / ArmParticipant Group / Arm |
Intervention / TreatmentIntervention / Treatment |
|---|---|
|
Experimental: 3D translabial ultrasound
3D translabial ultrasound with concurrent vaginal manometry
|
All patients will undergo 3D translabial ultrasound with vaginal manometry
|
What is the study measuring?
Primary Outcome Measures
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
3D ultrasound images and pressure/volume measurements of vagina in patients with pelvic organ prolapse
Time Frame: 1 hour and 20 minutes (i.e. the estimated time for the ultrasound and manometry examination per participant).
|
3D ultrasound images of the vaginal canal and the pelvic floor will be obtained using various ultrasound probes.
Pressure and volume measurements (i.e.
manometry) will be obtained using a urodynamic system.
|
1 hour and 20 minutes (i.e. the estimated time for the ultrasound and manometry examination per participant).
|
Secondary Outcome Measures
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
|---|---|---|
|
Survey
Time Frame: 5 minutes
|
Participants will be asked to fill out a short survey about their experience with the pessaries they already use and the ultrasound examination process
|
5 minutes
|
Collaborators and Investigators
Sponsor
Sponsor
Collaborators
Collaborators
Study record dates
Study Major Dates
Study Start (Actual)
Study Start
Primary Completion (Actual)
Primary Completion
Study Completion (Actual)
Study Completion
Study Registration Dates
First Submitted
First Submitted
First Submitted That Met QC Criteria
First Submitted That Met QC Criteria
First Posted (Actual)
First Posted
Study Record Updates
Last Update Posted (Actual)
Last Update Posted
Last Update Submitted That Met QC Criteria
Last Update Submitted That Met QC Criteria
Last Verified
Last Verified
More Information
Terms related to this study
Additional Relevant MeSH Terms
Other Study ID Numbers
Other Study ID Numbers
- 113264
- 6086 (Other Identifier: ReDA)
Plan for Individual participant data (IPD)
Plan to Share Individual Participant Data (IPD)?
Drug and device information, study documents
Studies a U.S. FDA-regulated drug product
Studies a U.S. FDA-regulated device product
product manufactured in and exported from the U.S.
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.